142 related articles for article (PubMed ID: 1612505)
41. Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial.
Tomirotti M; Perrone S; Giè P; Canaletti R; Carpi A; Biasoli R; Lombardi F; Giovanninetti A; Mensi F; Villa S
Tumori; 1988 Oct; 74(5):573-7. PubMed ID: 3217992
[TBL] [Abstract][Full Text] [Related]
42. Chemotherapy consisting of cisplatin, doxorubicin and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg.
De Pree N; Wils J
Anticancer Res; 1989; 9(6):1873-5. PubMed ID: 2697191
[TBL] [Abstract][Full Text] [Related]
43. Intraperitoneal cisplatin with intravenous cyclophosphamide and doxorubicin for previously untreated stage III and IV ovarian carcinoma.
Young JA; Garretson F; Westlake DL; Illig WP; Vogl SE
Cancer Invest; 1989; 7(6):565-70. PubMed ID: 2630007
[TBL] [Abstract][Full Text] [Related]
44. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).
Levenback C; Burke TW; Silva E; Morris M; Gershenson DM; Kavanagh JJ; Wharton JT
Gynecol Oncol; 1992 Sep; 46(3):317-21. PubMed ID: 1526508
[TBL] [Abstract][Full Text] [Related]
45. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia.
Lancet; 1987 Aug; 2(8555):353-9. PubMed ID: 2886821
[TBL] [Abstract][Full Text] [Related]
46. Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.
Reichman B; Markman M; Hakes T; Hoskins W; Rubin S; Jones W; Almadrones L; Ochoa M; Chapman D; Saigo P
J Clin Oncol; 1989 Sep; 7(9):1327-32. PubMed ID: 2671288
[TBL] [Abstract][Full Text] [Related]
47. [Effectiveness of 3-drug therapy in patients with advanced ovarian cancer].
Kwaśniewska-Rokicińska C; Kaleta B; Kumor-Głodny T
Ginekol Pol; 1989 Feb; 60(2):86-9. PubMed ID: 2680790
[TBL] [Abstract][Full Text] [Related]
48. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma.
Eifel PJ; Gershenson DM; Delclos L; Wharton JT; Peters LJ
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1013-8. PubMed ID: 1917596
[TBL] [Abstract][Full Text] [Related]
49. Treatment of advanced ovarian cancer with cisplatin, adriamycin and cyclophosphamide (PAC).
Diaz-Rubio E; Escudero M; Martin-Jimenez M; Vidart JA; Gonzalez-Larriba JL; Herraiz MA; Lopez Vega JM; Bullon F
Eur J Gynaecol Oncol; 1989; 10(6):424-32. PubMed ID: 2627975
[TBL] [Abstract][Full Text] [Related]
50. A randomized study of sequential versus alternating combination chemotherapy in advanced ovarian carcinoma.
Lund B; Hansen M; Hansen HH; Thomsen HK; Sørensen BL; Nielsen NC; Lundvall F
Ann Oncol; 1990; 1(2):134-40. PubMed ID: 2127690
[TBL] [Abstract][Full Text] [Related]
51. Long term results of cyclophosphamide, adriamycin and platinum chemotherapy in advanced epithelial ovarian cancer.
Harding M; Milsted R; Hole D; Cordiner J; Barr W; Soukop M; Kennedy J; Soutter WP; Kaye S
Ann Oncol; 1991 Mar; 2(3):231-3. PubMed ID: 2043495
[TBL] [Abstract][Full Text] [Related]
52. Neoadjuvant chemotherapy in stage X ovarian carcinoma.
Chambers JT; Chambers SK; Voynick IM; Schwartz PE
Gynecol Oncol; 1990 Jun; 37(3):327-31. PubMed ID: 2351315
[TBL] [Abstract][Full Text] [Related]
53. Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.
Leonard RC; Smart GE; Livingstone JR; Cornbleet MA; Kerr GR; Fletcher S; Webb JN; Smyth JF
Cancer Chemother Pharmacol; 1989; 23(2):105-10. PubMed ID: 2491962
[TBL] [Abstract][Full Text] [Related]
54. Experience in the treatment of epithelial ovarian carcinoma with cisplatinum-containing combination chemotherapy and dose intensity calculation.
Piura B; Glezerman M; Cohen Y
Eur J Gynaecol Oncol; 1990; 11(5):389-93. PubMed ID: 2097156
[TBL] [Abstract][Full Text] [Related]
55. Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma.
Shelley WE; Carmichael JC; Brown LB; Fraser RC; Kirk ME; Krepart GV; Levitt M; Roy M; Willan AR; Wilson KS
Gynecol Oncol; 1988 Feb; 29(2):208-21. PubMed ID: 3338672
[TBL] [Abstract][Full Text] [Related]
56. Short-duration (three cycles) cisplatin combination chemotherapy with alkylating agent consolidation in advanced epithelial ovarian cancer.
Lawton FG; Hilton C; Mould JJ; Chan KK; Blackledge G
Gynecol Oncol; 1991 Mar; 40(3):225-9. PubMed ID: 2013444
[TBL] [Abstract][Full Text] [Related]
57. Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: a Southwest Oncology Group Study.
Alberts DS; Mason-Liddil N; O'Toole RV; Abbott TM; Kronmal R; Hilgers RD; Surwit EA; Eyre HJ; Baker LH
Gynecol Oncol; 1989 Jan; 32(1):8-15. PubMed ID: 2642455
[TBL] [Abstract][Full Text] [Related]
58. Intraperitoneal doxorubicin in combination with systemic cisplatinum and cyclophosphamide in the treatment of stage III ovarian cancer.
Deppe G; Malviya VK; Boike G; Young J
Eur J Gynaecol Oncol; 1991; 12(2):93-7. PubMed ID: 2055231
[TBL] [Abstract][Full Text] [Related]
59. Lack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemotherapy.
Piver MS; Baker TR; Driscoll DL
Eur J Gynaecol Oncol; 1990; 11(4):243-50. PubMed ID: 2245807
[No Abstract] [Full Text] [Related]
60. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
